ORCL vs TRAW · P/E 31, rev $67.36B vs rev $2.8M
Oracle Corporation (ORCL) versus Traws Pharma Inc (TRAW) — a side-by-side from cached financials, not a winner call.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
ORCL currently screens at market cap $527.84B and trailing P/E 31.4. TRAW currently screens at market cap $12.1M.
Not investment advice. Open the ORCL and TRAW stock pages for the full models.
Not investment advice.